BioNJ Thanks Our Renewing Members:

BioNJ thanks our renewing Preferred Members:

EisnerAmper, LLP
EisnerAmper’s Life Sciences Practice professionals have the expertise, resources and relationships to assist both public and private life sciences companies bridge the gap between business and science. In addition to the traditional tax and accounting services, Amper also assists our life sciences clients with services spanning the entire development cycle of companies.

Merck & Co., Inc.
Merck & Co., Inc. is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines, but help deliver them to the people who need them.

Sanofi, a diversified global healthcare leader, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With more than 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi U.S., with headquarters in Bridgewater, New Jersey, employs more than 17,000 professionals throughout the country. At Sanofi, we work for what really matters: health.

Drinker Biddle & Reath, LLP
Drinker Biddle & Reath’s Life Sciences Group is built from our interdisciplinary practice groups, comprised of attorneys who have experience, knowledge and insights about navigating the fast-paced, heavily regulated environment that surrounds scientific research, life sciences product development, intellectual property protection, employment issues and litigation, product marketing and sales and health care delivery. We support our life sciences clients on issues relating to business and financing pressures, regulatory scrutiny, workforce management and litigation threats. We strive to provide collaborative and strategic advice and value the opportunity to partner with our clients in facing their business and legal challenges.

BioNJ thanks our renewing Innovation Members:

Agile Therapeutics, Inc.
Agile Therapeutics is a specialty pharmaceutical company focused on developing and commercializing innovative women’s healthcare products that address unmet needs.  Agile was founded in 1997 and is headquartered in Princeton.

AlfaGene Bioscience, Inc.
AlfaGene BioScience, Inc. is a prime source of genomics and proteomics products for biopharmaceutical industries and research institutions. The company gives expert advice and customized services to fit any client’s project needs, from library construction and gene identification to protein expression and purification.

Amarin Pharma, Inc.
Amarin Corporation is a late-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. Amarin is developing AMR101, a prescription-grade omega-3 fatty acid, as a prescription medicine for the treatment of patients with very high triglyceride levels (≥500 mg/dL) and as a potentially first-in-class therapy for patients with high triglyceride levels (≥200 and <500mg/dL) who are also on statin therapy for elevated LDL-cholesterol levels (mixed dyslipidemia). Amarin’s cardiovascular programs capitalize on Amarin’s expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in treating cardiovascular disease.

Amicus Therapeutics, Inc.
Amicus Therapeutics is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases. The company has a robust development pipeline of novel, first-in-class treatments for a broad range of human genetic diseases.

Ascendia Pharmaceuticals, LLC
Ascendia Pharmaceuticals LLC, founded in 2012, is a privately owned specialty pharmaceutical company, engaged in the research and development of innovative specialty pharmaceutical products, leveraging its proprietary drug delivery technologies including amorphous solid dispersion, injectable and controlled release for difficult-to-formulate drug candidates.

Bezwada Biomedical, LLC
Bezwada Biomedical, LLC is an innovation driven, start-up company catering to the unmet needs of the biomaterial community and medical device industry. With our state-of-the-art research and development facilities in the U.S. and India, combined with our platform technologies derived from a family of novel and proprietary biodegradable polymeric biomaterials, we work with and for our customers to translate their demands into high quality products for a wide range of medical device and therapeutic applications in a cost effective manner.

Caladrius Biosciences, Inc.
Caladrius Biosciences is a biopharmaceutical company pursuing the preservation and enhancement of human health globally through the development of novel cell based personalized medicine therapeutics that prevent, treat or cure disease. The company is developing therapies based on three platform technologies (immune-oncology, ischemic repair and immunomodulation) with a lead, late-stage (Phase 3, 2 and 2, respectively) clinical program for each. The combination of a rich therapeutics pipeline and an externally recognized in-house center for cell therapy process development and manufacturing has created an organization with unique capabilities for accelerated and efficient product development.

Celator Pharmaceuticals, Inc.
Celator Pharmaceuticals, Inc. is an oncology-focused, clinical development stage company with products developed based on proprietary technology for identifying synergistic drug ratios, fixing the desired ratio in a drug delivery vehicle in order to maintain the ratio in patients and improve clinical outcomes.

Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates.

Chugai Pharma USA, LLC
Chugai Pharma USA, LLC (CPUSA), located in Berkeley Heights, NJ, is a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd. CPUSA supports the planning and execution of global and U.S. clinical programs for Chugai originated innovative new drug candidates. Chugai is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad and is working to develop innovative products which may satisfy the unmet medical needs in strategic fields of oncology, bone and joint diseases and renal diseases as well as other therapeutic areas.

Churchill Pharmaceuticals LLC
Churchill Pharmaceuticals, LLC is a private, development-stage pharmaceutical company devoted to small molecule innovation within oncology, designed to enhance patient outcomes. The lead Churchill oncology product utilizes a proven, proprietary, and patented nanotechnology process; SoluMatrixä Fine Particle Technology, submicron-sized drug particles that are 10 to 200 times smaller than conventional formulations. By leveraging the SoluMatrixä technology, Churchill is addressing a common oral oncology product challenge, the attainment of optimal therapeutic blood levels. Our objective is to maximize these product development core competencies, fueling future oncology and hematology product development and commercialization.

ContraVir Pharmaceuticals, Inc.
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against the FDA-approved drugs used for the treatment of shingles. Preclinical studies demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels.

Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel drugs to treat human cancers and other serious disorders. The company’s strategy is to build a diversified biopharmaceutical business based on a portfolio of commercial products and a development pipeline of novel drug candidates.

Drais Pharmaceuticals, Inc.
Drais Pharmaceuticals, Inc. is a privately held drug development company based in Bridgewater, New Jersey. We are focused on early and mid-stage clinical development, through proof of concept, with a current pipeline of three compounds. The management team consists of highly experienced, seasoned individuals with outstanding track records in the pharmaceutical industry. Prior to forming Drais, the management team founded AkaRx, Inc., successfully guiding their lead compound into Phase 2 proof of concept and negotiating the sale of the company to Eisai, Inc. in 2010.

Edge Therapeutics, Inc.
Edge Therapeutics uses a novel, site-specific and sustained release-microparticle technology platform to deliver drugs to the brain and treat acute, and fatal or debilitating neurological conditions that currently have no effective therapies. Edge works with some of the world’s foremost scientists from leading academic research centers to develop proprietary and novel formulations of known active drugs for direct therapeutic delivery to the site of injury in the brain.

Elusys Therapeutics, Inc.
A privately-held biopharmaceutical company focused on the development of antibody-based therapies for the treatment of infectious disease. The company has pioneered the development of a rapid injection, therapeutic antibody, Anthim™, for the treatment of anthrax infection following a bio-warfare attack.

Emisphere Technologies, Inc.
Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on the commercialization of its own product candidates using its Eligen® Technology, a unique and improved delivery of therapeutic molecules. Our core business strategy is to commercialize the Eligen® Technology through the launch of Oral Eligen® B12 globally, grow our delivery systems business through new and enhanced strategic alliances and reprioritize our product pipeline.

Enteris BioPharma, Inc.
Enteris BioPharma is a clinical-stage biopharmaceutical company using its proprietary formulation technology to repurpose drugs from injection to oral route of administration. Since the company’s inception in 2013, Enteris has developed a pipeline of products that offer the potential to dramatically improve patient treatment options in a variety of important indications. We aim to develop and market clinically valuable medicines that meet significant medical needs and generate financial value to reward our stakeholders. Additionally, Enteris BioPharma partners with biotech and pharma in providing innovative oral drug delivery solutions for peptides and small-molecules as well as contract manufacturing services.

EpiGen Pharmaceuticals, Inc.
EpiGen Pharmaceuticals is a clinical stage pharmaceutical company based in Princeton, NJ, focused on the development of cardiac reperfusion therapies.  The company was founded with support from the University of Pennsylvania Center for Technology Transfer.

Evotec, Inc.
Evotec is a drug discovery solutions company providing drug discovery expertise and capabilities to pharmaceutical and biotechnology companies as well as to academic institutions. Drug discovery solutions are provided in form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of innovative drug candidates and consulting arrangements. The company operates worldwide and has leading scientific experts, state-of-the-art technologies, as well as key therapeutic expertise in the areas of neuroscience, pain, metabolic diseases, oncology, inflammation and infectious diseases. By leveraging this expertise, Evotec intends to develop best-in-class and first-in-class differentiated therapeutics on its systematic, unbiased and comprehensive infrastructure.

Geistlich Pharma North America, Inc.
Geistlich Pharma is the global leader in regenerative medicine in dental and oral-maxillofacial surgery with biomaterials targeted for bone and soft tissue regeneration. The company’s expertise in collagens extends to matrices for bone and cartilage regeneration in orthopedics, trauma and sports medicine. Geistlich Pharma also has a portfolio of proprietary pharmaceuticals and OTC products. Based in Switzerland, the company has a 160 year history of science based, high quality innovation.

Genmab, US Inc.
Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using unique, cutting-edge antibody technology, Genmab’s world class discovery and development teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options.

Grunenthal, USA, Inc.
Grünenthal USA is a subsidiary of Grünenthal GmbH, an independent, family-owned multi-national research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, Grünenthal’ s objective is to become the most patient-centric company and thus to be a leader in therapy innovation. Beyond its outstanding Research and Development capabilities, The Grünenthal Group has full commercial operations in Europe, Australia and Latin America. In North America, the Group focuses on the licensing of innovative compounds and technologies to leading pharmaceutical companies with strong presence in the U.S. and Canadian markets.

GSG Scientific, LLC
GSG Scientific LLC, located at the Princeton Corporate Plaza Research Center in NJ, provides support for research projects in the food and healthcare industries. We have an expert team of information professionals and scientists to collect and analyze literature and prepare scientific and government agency required reports. Our team provides information for chemistry, pharmaceutical and biotechnology innovation at all stages of product development including chemical searches, animal research alternatives, preclinical research, clinical trials, regulatory landscapes, pharmacovigilance and toxicology and product safety. In addition, we have a small laboratory for bench scale research services specializing in troubleshooting technical issues.

HDL Apomics
HDL Apomics is taking a high-density lipoprotein (HDL) – centric view as the basis for progressing our understanding of cardiovascular disease and its associated complications through risk profiling based on measuring the dynamic status of an individual’s HDL particle population. Currently in development, our multiplex antibody array will generate a high-definition “HDL fingerprint” directly from plasma.  Fingerprint matching against our genetic and disease-state sample library enables assessment of cardiovascular disease and through proprietary analytics will develop validated biomarkers for diagnosis, risk assessment and response to therapy. HDLApomics will offer diagnostic services to the pharmaceutical and biotechnology industry to markedly improve success rates in clinical trials and reduce time to market, ultimately affording improved quality of patient care.

Helsinn Therapeutics (U.S.), Inc.
Helsinn is a privately owned cancer supportive care pharmaceutical group with an extensive portfolio of marketed products and a broad development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values of respect, integrity and quality, through a unique integrated licensing business model working with long standing partners in pharmaceuticals, medical devices and nutritional supplement products. Helsinn is headquartered in Lugano, Switzerland, with operating subsidiaries in Ireland and the U.S. (Helsinn Therapeutics), a representative office in China, as well as a product presence in about 90 countries globally.

InteguRX Therapeutics LLC
InteguRx has developed a proprietary transdermal drug delivery platform which achieves exceptionally robust enhancement of skin penetration, enabling significant value creation by addressing unmet medical needs. Our lead product is an ondansetron gel designed to treat pregnancy-induced nausea and vomiting. We are simultaneously assessing several other product development opportunities in both the Women’s Health and CNS/analgesia therapeutic areas which can be engineered as either gels or transdermal patches utilizing our platform.

Ipsen Biopharmaceuticals
Ipsen is a global specialty driven biotechnological group with total sales exceeding €1.2 billion in 2014 in more than 115 countries, with a direct commercial presence in 30 countries. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Our strategy is supported by three franchises: neurology, endocrinology and urology-oncology. Ipsen’s commitment to oncology is exemplified through its growing portfolio in prostate cancer, bladder cancer or neuro-endocrine tumors. Ipsen also has a significant presence in primary care.

Macroceutics, Inc.
Macroceutics, Inc. is a new biotechnology company focused on discovering and developing macrocycles as potential treatments across multiple medical indications in oncology and ophthalmology. The novel molecular structure of macrocycles will enable us to target not only the same cancer cell-surface targets currently dominated by therapeutic monoclonal antibodies (mAbs) and antibody-drug-conjugates (ADCs), but also additional inter- and intra-cellular cancer and ophthalmology targets, including those for which there are either sub-optimal or no existing therapies. We possess the proprietary platform technology and macrocyclic chemistry expertise to discover high-potency macrocycles against these biological targets. We are developing our macrocyclic drugs to address the systemic need for new therapies that work differently and at a lower overall cost.

Orthobond Corporation
Orthobond uses proprietary non-polymer technology developed at Princeton University to enhance the surface characteristics of medical grade substrates. This unique attachment chemistry can be customized to provide medical companies with surfaces that improve the performance of their metallic and polymeric implants, instruments and ancillary components. Orthobond is currently focused on using this technology to create antimicrobial surfaces that may help to reduce the risk of infection associated with medical implants. Other applications include, but are not limited to, improving adhesion between surfaces, making surfaces hydrophobic or hydrophilic, or attaching specific molecules such as proteins, peptides and/or small molecules to a surface.

OrthogenRX Inc.
OrthogenRx, Inc. is a late stage development company focused on the development of Class III generic orthopedic medical devices. The business model is to identify products being sold ex-U.S. that are identical to currently marketed U.S. products and license them for commercialization in the U.S. Of particular interest are Class III medical devices that presently have limited competition in the U.S. market place and no patent protection. The initial focus is on a class of products that had $714MM in sales in the U.S. 2011. Several suppliers of targeted products have been identified and licensing/supply agreements have been executed.

PanOptica, Inc.
PanOptica, Inc. is a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies. The company was founded in March 2009 by Paul Chaney, past president of OSI Eyetech and Martin Wax MD, who formerly headed Pharmaceutical R&D at Alcon. In December 2010, PanOptica, Inc. raised $30 million in a Series A financing led by SV Life Sciences and Third Rock Ventures. The completion of this financing coincides with the company’s successful licensing of exclusive worldwide ophthalmic rights to PAN-90806 from OSI Pharmaceuticals, Inc., a wholly-owned subsidiary of Astellas US Holding, Inc. for the treatment for neovascular age-related macular degeneration, also known as wet AMD.

Paramesh Banerji Life Sciences, LLC
Paramesh Banerji Life Sciences, LLC is the U.S. manufacturing company of Dr. P. Banerji’s Telemedicine Center. The operation will manufacture the medications prescribed for all United States current and future patients. Our medications are manufactured to the strict homeopathic formulas that are proprietary to Dr. P. Banerji. All manufacturing will take place using cGMPs (Current Good Manufacturing Practices) and all FDA regulated guidelines.

Photocure ASA, headquartered in Oslo Norway, is a specialty pharmaceutical company and world leader in photodynamic technology. Based on our unique proprietary Photocure Technology™ platform, Photocure develops and commercializes highly selective and effective solutions within disease areas with high unmet medical need, such as bladder cancer, HPV and precancerous cervical lesions, colorectal cancer and skin conditions.

PTC Therapeutics, Inc.
PTC Therapeutics, Inc. (PTC) is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC has assembled proprietary technologies and extensive knowledge of post-transcriptional control processes that it applies in its drug discovery and development activities. PTC’s current pipeline of clinical and preclinical product candidates addresses multiple indications, including genetic disorders, oncology and infectious diseases.

Rxi Pharmaceuticals, Corp.
RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform.  Therapeutics that use RNA interference, or “RNAi,” have great promise because of their ability to “silence,” or down-regulate, the expression of a specific gene that may be overexpressed in a disease condition. Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, RXi’s first RNAi product candidate, RXI-109, entered into RXi’s first human clinical trial in 2012. RXI-109 targets connective tissue growth factor (CTGF), a key regulatory of fibrosis and scar formation, and is initially being developed to reduce or inhibit scar formation in the skin following surgery.

S1 BioPharma, Inc.
S1 Biopharma is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of drug therapies for Hypoactive Sexual Desire Disorder (HSDD) and related sexual dysfunctions.

SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.

Soligenix, Inc.
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.

Symphogen Inc.
Symphogen Inc. is the U.S. subsidiary of Symphogen A/S. Symphogen A/S is a private biopharmaceutical company leading the field of recombinant antibody mixtures for therapeutic use.  The European-based company is developing next-generation antibody therapeutics for the treatment of human cancer.  Symphogen is dedicated to bringing truly innovative oncology products to the market by creating optimally selected antibody mixtures that address multiple oncology targets in a single drug product.  Symphogen’s corporate headquarters and research departments are based in Denmark, while it is currently establishing a U.S. subsidiary, Symphogen Inc., to focus on global clinical development of its therapeutic agents.

ThromboGenics, Inc.
ThromboGenics is an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines. The company’s lead product, JETREA® (ocriplasmin), has been approved by the U.S. FDA for treatment of symptomatic VMA and was launched in January 2013. ThromboGenics is headquartered in Leuven, Belgium, and has offices in Iselin, NJ (U.S.) and Dublin, Ireland. As of May 2014, ThromboGenics employs 44 people in New Jersey out of its total U.S. workforce of 88. The company is listed on the NYSE Euronext Brussels exchange under the symbol THR.

Thymon LLC.
Thymon, LLC, founded in 1996 by Dr. Gideon Goldstein, functions as a virtual company with all laboratory and clinical studies directed and funded internally but performed externally by contracted organizations. The company is the assignee of seven issued Goldstein patents covering a synthetic universal HIV-1 Tat epitope vaccine (TUTI-16) and a human monoclonal antibody (tepiumab) universally reactive with HIV-1 Tat protein. HIV-1 Tat protein is essential for maintenance of HIV set point viremia and an exploratory randomized, placebo-controlled study of TUTI-16 in untreated HIV infected subjects yielded a highly significant reduction in viral load following immunization. This study supported the feasibility of TUTI-16 as a potential prophylactic and therapeutic HIV/AIDS vaccine and the feasibility of tepiumab for antiretroviral treatment.

BioNJ thanks our renewing Associate Members:

6 Degrees Communications
As a results-oriented, full-service public relations firm that serves clients across the healthcare spectrum, we deliver experiences that are meaningful, tangible, quotable, distinguishable and indelible, setting our work apart from our competition. Our offering is unique; first, our plans focus on your business objectives. Second, we are defined by our relationships. Finally, we execute. Plans are only as good as the people implementing them, and our nimble, senior-based model means we deliver business-changing results. We are uniquely positioned to help transmit messages through the web by leveraging our unparalleled experiences gained and relationships earned inside the world’s most powerful media institutions, regulatory bodies and corporations.

ACT Oncology
ACT Oncology is a specialized oncology CRO comprised of highly experienced clinical research professionals. Founded by Patricia Devitt Risse, PharmD, in 2000, and certified as a Woman-owned Business Enterprise by the State of New Jersey, the company has expanded from a core group focused on specific high-level oncology operations to a robust organization providing broad, full-service support for Phase I-III oncology programs and registries. Our clients have diversified to include leading biotech, pharma and non-profit oncology organizations. And because of our flat organizational structure, which focuses on supporting our project teams, sponsors receive flexible, responsive and cost-effective services.

Acumen BioPharma
Acumen BioPharma is a One-Stop Biopharmaceutical Expert-Witness Services providing intellectual property law firms and the biopharmaceutical industry with the scientific foundation to build the winning argument regarding patent infringement. Our services include leading academics with stellar scientific credentials and experience as expert witnesses; measurement and characterization services providing unparalleled access to academic laboratories equipped with state-of-the-art equipment and modeling methodologies for process and material characterization; and literature searches and deep scientific evaluation to back up infringement/non-infringement position. We deliver reliable, timely services utilizing respected scientific experts with absolute integrity.

Advance Realty
Advance Realty, headquartered in Bridgewater, New Jersey, is a privately held real estate development, investment and management company. Since its inception in 1979, Advance Realty has acquired or developed more than 10 million square feet of commercial, residential, mixed-use and industrial projects. Advance’s most recent acquisition includes the New Jersey Center of Excellence at Bridgewater which is a 1.2 million square foot premier research and development Campus situated on 110 acres along U.S. Highway 202/206 in Bridgewater, New Jersey. The Campus features +/- 500,000 square feet of state-of-the-art biology and chemistry laboratory and vivarium space, + 200,000 square feet of executive/general office, in addition to + 400,000 square feet of build-to-suit office available.

Aesclepius Sciences, LLC
Aesclepius Sciences is an advisory company for both start-up and established organizations specializing in translational medicine and clinical development. Due to experience with six pharmaceutical product regulatory approvals, we advise and where necessary, coordinating the execution of clinical development protocols, clinical investigations, preparation of study reports and regulatory summaries, briefing documents and responses to regulatory questions. We support preparation of funding proposals going to private capital as well as government agencies. We pride ourselves in a fact based, science and business approach. Our objective is to serve the interests of the most important customer, the patient.

Ashton Tweed, LTD
Ashton Tweed, LTD is a robust professional force of highly experienced life sciences industry experts who are deployed throughout the company’s diverse range of service offerings to solve clients’ human capital and commercialization management needs. The company excels in finding the right candidates for clients’ workforces at all points of growth and across all specialized staffing needs.

Baker Tilly Virchow Krause, LLP
Baker Tilly Virchow Krause, LLP is one of the oldest and largest certified public accounting and consulting firms in the U.S. As an independent member of Baker Tilly International, the world’s 8th largest network of accounting firms, we bring you access to market-specific knowledge in 137 countries.

Bench International
Bench International is a global Women’s Business Enterprise (WBENC)-certified retained executive recruiting and consulting firm serving the life sciences sector, exclusively, since 1974. We pride ourselves as being one of the top executive recruitment providers for the sector, with a team that is deeply experienced and accomplished and has the content knowledge and expertise to translate and meet our clients’ needs and expectations for executive talent. Our vision, simply put, is to make life-changing placements so our clients can change lives. Bench International is headquartered in Los Angeles, California, with hubs in New York, the United Kingdom, Switzerland and Australia.

Biggins Lacy Shapiro & Company, LLC
Biggins Lacy Shapiro & Company (BLS & Co.) helps some of the world’s largest corporations identify the best locations, negotiate incentives, secure development approvals and optimize energy strategies. Location Economics™, our trademarked multi-disciplinary approach, focuses on creating value for companies and their communities. Our achievements derive from our best-in-class combination of creativity, objectivity and independence. Our project teams incorporate a unique blend of attorneys, finance and tax experts, planners and engineers. BLS & Co. serves clients in four practice areas: site selection, incentives advisory, land use strategies and approvals and energy services.

BioBridges, LLC
BioBridges represents and manages the careers of experienced; highly sought after industry professionals who make an immediate, positive impact on the pharmaceutical, biotech and medical device programs they serve.

BioConsulting International, LLC
BioConsulting International, LLC (BCI) works to provide practical answers to the myriad of complex problems that arise in life sciences, in vitro diagnostic and biotech business operations. Whether the challenges present themselves in the development, manufacturing or quality facets of a project or whether external factors may be in play, the sole focus of our service is to quickly assess the particular client business situation and recommend immediate and mid-term solutions that are custom fit to the organization’s capabilities. We work with small, medium and large firms on a variety of projects that span a range of operational, technical and compliance-based issues.

Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc., specializes in the preparation and review of CBER regulatory applications (INDs and BLAs), as well as the inspection/audit of biologics manufacturing facilities but also in similar regulatory activities for drugs, devices and combination products.

CBRE Group, Inc., a Fortune 500 and S&P 500 company headquartered in Los Angles, is the world’s largest commercial real estate services firm in terms of 2011 revenue. The CBRE Life Sciences Group, with 70 members worldwide, is dedicated to providing the life sciences industry with the highest level of real estate services available. The New Jersey based professionals in this group deliver unique expertise and focus to meet specific needs for the biotech, pharmaceutical, medical device and related industries. Deeply rooted in the New Jersey life science sector and backed by CBRE’s robust resources, strengths and integrated service delivery platform, our advisors offer solutions that address virtually all real estate related needs for owners and occupiers.

Cedarbrook Corporate Center
Cedar Brook Corporate Center offers an ideal work environment for science and technology minded companies. Our expert team has many years of experience delivering state-of-the-art facilities to help grow your business, attract new employees and impress clients. We are a choice location for both established and emerging companies. Situated on 150 beautifully manicured acres with a 10 acre lake and walking paths, tenants can enjoy the surroundings while being productive. Cedar Brook offers executive office space tailored to suit a variety of tenant sizes with opportunities for future expansion, as well as chemistry and biology lab space to companies within the research, biotech, technology, pharma, manufacturing, electronic and life sciences sectors.

Chemical and Pharmaceutical Solutions
Chemical and Pharmaceutical Solutions was founded in 2002. Our primary focus is servicing the emerging pharmaceutical market and to assist those companies in developing and commercializing their API’s. We look at both the technical and regulatory aspects of taking a product from early development through commercial launch. Working with outside partners, we look at economic drivers of your process and the technical challenges around scale up including improved purification methods as well as continuous flow chemistry. We also work closely with the venture capital firms to evaluate the technical and regulatory aspects of potential licensed products.

Cornerstone Search Group
Cornerstone Search Group is a specialized pharmaceutical/biotechnology executive search and recruitment firm located in the heart of New Jersey’s pharmaceutical corridor. Cornerstone Search Group helps its pharmaceutical/biotechnology clients identify, attract and hire accomplished professionals from the experienced staff levels through the senior leadership ranks who are involved with the discovery, development and commercialization of drugs/therapeutic treatments for the U.S. and international markets. Cornerstone Search Group’s team of highly experienced pharmaceutical/ biotechnology specialty consultants/recruiters are adept at using their industry knowledge and contacts to generate desired results for their clients and candidates.

Coyne PR
Coyne PR is a full-service, integrated communications agency with expertise in a variety of industries. Prominent clients include The Walt Disney Company, Hard Rock International, Red Robin Gourmet Burgers, Chrysler, Goodyear Tire & Rubber Company, Shell Lubricants, Columbia Business School and Pfizer. Fueled by the agency’s mission to be the best place to work, employees deliver high-profile programs that drive visibility, engagement and growth for many of the world’s most-trusted brands. The agency has evolved far beyond its PR roots with a dedicated social media practice, an award-winning digital design group and a full advertising and marketing team.

CRC Pharma LLC
CRC Pharma is managed by the executive team which has more than 80 total years of direct pharma development experience in the planning, execution and management of clinical trials primarily in the areas of biometrics (biostatistics and statistical programming) and medical/scientific/regulatory writing. Few representative examples of companies served by the CRC Pharma are: Novartis, Johnson and Johnson, Eli Lilly, Schering Plough, Merck, Aventis, Organon and Xoma.

Since 1997, we’ve been providing innovative solutions to meet the complex clinical supply challenges pharmaceutical and biotechnology companies’ face. Our team manages the clinical supply chain for hundreds of satisfied clients worldwide, providing services that keep clinical trials on time and on budget. CSM offers a full suite of cGMP-compliant services, continually delivering quality supplies to clinical sites and patients around the world. From Phase I all the way to large Phase III projects, we have the flexibility to meet the needs of all projects regardless of size and scope. Our customer-centric approach, revolutionary processes and state-of-the-art clinical services increase efficiencies, reduce costs and improve outcomes for clinical trials of any size or scope.

Defined Health
Defined Health is a leading biopharmaceutical asset development strategy consultancy whose clients include a mix of global pharma and biotech, emerging biotech, specialty pharmaceutical companies and investors. Our services include Compound and Platform Technology Assessments, Forecasting, Identification and Evaluation of Partnering Opportunities, Indication Prioritization and Sequencing and Therapeutic Area Growth Strategies. Defined Health’s consultants hold advanced degrees in science, medicine and business and have industry experience in business development, commercial evaluation, finance, licensing, drug discovery and R&D. Defined Health annually sponsors Cancer Progress in March, and Therapeutic Insight in conjunction with EBD Group’s BioEurope Spring Partnering Conference.

Epsen Fuller/IMD International
Epsen Fuller/IMD International’s only purpose is to serve organizations in reaching their goals and individuals in realizing their full potential. We are committed to delivering world-class service in talent acquisition and individual and organizational development. We have the courage to say and do what is right, behave ethically, promote diversity, respect one another, build trust, show kindness to all and respond with integrity and transparency with everyone we touch. Through teamwork and collaboration, we serve one another, encourage one another and build one another up.

Franzwa Real Estate Advisors, LLC
Franzwa Real Estate Advisors, LCC offer commercial real estate services; office tenant representation within specialty in life sciences, lab, R&D, pilot plant and manufacturing facilities; leasing and sales and acquisitions and dispositions.

GENEWIZ, Inc. is a leading global genomics service company providing DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics and GxP/CLIA regulatory and clinical services. GENEWIZ is dedicated to accelerating scientific discovery, as well as to developing and delivering innovative solutions for translational medicine. With a core business model based on operational excellence and customer support, GENEWIZ is known for fast reliable results, specialized expertise, competitive pricing, excellent project management and award-winning, friendly technical support. GENEWIZ is the preferred partner at leading academic, pharmaceutical, biotechnology, agricultural, government and clinical institutions with a network of easily accessible global laboratories.

Gilman Performance Systems, Inc.
Gilman Performance Systems is a full service human resources development training and consulting firm leading the way in helping to develop the skills needed for your future. The GPS philosophy is a truly personal approach that will help in meeting goals and being successful. Since 1986, GPS has been nationally recognized for its highly professional and effective meetings. GPS caters specifically to those they are working with to get needed results through increase productivity, strengthened leadership and more effective communication skills. GPS lead trainers are all former managers oft, each with 20+ years of experience.

Grant Thornton LLP
Grant Thornton LLP, the U.S. member firm of Grant Thornton International, is one of the six global accounting, tax and business advisory firms. Grant Thornton LLP provides a level of service that fosters the individual service relationships our clients expect.

Hays Life Sciences
Hays Life Sciences provide comprehensive talent management and acquisition solutions for life sciences/technology based organizations. Our core service offerings include: mid- to senior-level executive search, exclusive contingency search, recruitment process outsourcing and contract/contract to hire management recruitment solutions. Hays consultants function as cross-functional vertical specialists within the life sciences market. Utilizing a niche focus model along with a branded proprietary in-house technologies, robust active networks and best-in-class customer service standards has resulted in effectively meeting our clients’ talent acquisition requirements. Service offerings and capabilities include access and utilization at all levels/phases of the recruitment life cycle process.

Inifinity Resources, LLC
Infinity Resources’ mission is to assist our clients in their growth through providing the highest caliber candidates that can drive the process within an organization. Each organization is unique in its culture, philosophies and market needs. All cannot survive without their most important corporate asset –people. We provide the executive talent that drives your growth. Our rigorous process and industry knowledge, combined with the solid building blocks necessary for client, candidate and internal relationships creates the basis for our success in servicing organizations.

Integrated Resources, Inc.
Integrated Resources, Inc. is a premier staffing firm recognized as one of the tri-states most well-respected professional specialty firms. IRI has built its reputation on excellent service and integrity since its inception in 1996.Our mission centers on delivering only the best quality talent, the first time and every time. We provide quality resources in four specialty areas: information technology (IT), clinical research, rehabilitation therapy and nursing.

JBK Associates International
JBK Associates, Inc. is a retainer-based, award-winning and woman-owned certified executive search firm with a strong focus on the life sciences and healthcare industries. Placing super-star talent in a wide array of functional specialties, JBK Associates, an AESC member, takes a fully-integrated talent management approach to help all size organizations achieve major growth by providing best-in-class solutions for search, staffing and organizational development. The firm has been recognized by Forbes, The American Business Awards, Diversity Business, Working Mother, PharmaVOICE  and New Jersey Business for its achievements and track record of success.

Kender Consulting, LLC
Kender Consulting, LLC is dedicated to supporting the management and development of people and organizations. We are passionate about people and understand their importance to achieving business success. We want to help individuals and organizations manage and develop their efforts in the most effective manner possible. At Kender Consulting, our experience has taught us that the secret is in the alignment. Our approach is simple and our solutions even simpler: Right Strategy, Right Processes, Right People.

Kybora Emerging Markets
Torreya EM is a global advisory firm focused on mergers and acquisitions, licensing and commercialization pharmaceutical products and medical devices in emerging markets. We distinguish ourselves by our global reach. In addition, the partnerships we have established, gives us access to the US, European Japanese, Russian and Indian markets. Our area of focus is exclusively on healthcare transactions. We have had a great success in helping small to mid-size companies located in emerging markets sell themselves to strategic and financial investors located all over the world. We also help healthcare companies maximize the value of their assets on a global basis through optimal licensing deals.

LeaderStrong, LLC
Leaderstrong is a boutique New Jersey-based leadership consulting, strategic advisory and executive coaching firm on a mission to dramatically increase the leadership impact of the high tech and biotech clients we serve in the New York to Philadelphia corridor. LeaderStrong helps clients increase the velocity and relevance of their organizations through our thought leadership in our proven and proprietary methodologies. Our highly tailored leadership programs enable our clients to get the hard hitting business results they desire.

McCarter & English, LLP
Twenty-first century business realities, driven by enhanced productivity tools, increased competition, a volatile, rapidly changing economy and the unique needs of and challenges confronted by clients, are creating paradigm shifts in the delivery of legal services. We created SORINROYERCOOPER to reinvent law firm practice to address these issues, especially for clients in the emerging growth and middle market sectors, including technology, communications, internet, alternative energy, nanotechnology and life sciences. We provide creative and sophisticated solutions characterized by the highest-quality lawyering and responsive service.

MPI Research
Our mission is to partner with biopharmaceutical and medical device companies globally to provide best-in-class, early-stage drug development services which ultimately results in safer, more efficacious products for the world. Our vision is to be recognized as the leading provider of early stage drug development services through integrity, dedication, innovation and focus with and among our Employees and our Sponsors.

New Jersey Health Foundation
New Jersey Health Foundation is a not-for-profit corporation that supports biomedical research and health-related education programs in New Jersey through several grants programs and its affiliate, Foundation Venture Capital Group which makes private equity investments in life sciences start- up companies in New Jersey headed toward commercialization.

Novasep, Inc.
Novasep, Inc. offers products and services to the pharmaceutical, biotech and industrial biotech markets. We provide solutions for process development and purification of final product from lab to turn-key industrial process using a range of techniques, including batch and continuous chromatography techniques, cross flow membranes and outsourcing manufacturing of biomolecules.

Orphan Reach USA, LLC
As the first patient centric contract research organization (CRO) orphan reach™ are here to accelerate the clinical development of orphan drugs and facilitate patient access to urgently needed new treatments for rare conditions. For our customers – innovative biotech companies – we provide global CRO services with particular attention to patient recruitment and retention enhanced by home nursing and patient travel support. Our infrastructure allows access to patients with rare diseases in more than 100 countries world-wide. Centrally based project management teams in Europe, USA and Asia co-ordinate our task force in each of the local territories and contribute their orphan expertise to accelerate access to new drugs in a wide range of therapeutic areas.

Quantex Laboratories
Quantex Laboratories is a contract drug discovery and research company providing comprehensive laboratory services to the pharmaceutical (Rx/Generic/OTC), biotechnology, medical device and other life sciences industries. We function in a collaborative research manner with our clients and customers, serving as an extension of their internal resources. We serve a diverse range of clients located in North America, South America, Europe, the Mid-East and Asia. These include Fortune 500 companies, global pharma/biopharma and medical device companies, as well as virtual and mid-sized companies. Our clients include many of the leading pharmaceutical, biopharmaceutical and medical device companies.

Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of services across the entire drug development process. For more than 25 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology and medical device companies, as well as academic and government organizations. Our commitment to excellence, our innovative technologies and our therapeutic expertise accelerate time to market, maximize returns on investments and lead to an exceptional customer experience.

Science Branding Communications
Science Branding Communications (SBC) works with their pharmaceutical, biotech and diagnostic clients to develop a MEDSTORY, a scientific-based story that differentiates products in a compelling, memorable, differentiated and exciting way. We excel at storytelling and crafting communication programs for phase 2 and early phase 3 products in oncology, neurology, cardiology, metabolic and respiratory medicine. SBC principals have years of top agency experience and manage a virtual network of global scientists, physicians, consultants, graphic artists, animators, producers and project managers.

SCIENION is a life sciences company well positioned in the markets of ultra-low volume liquid handling systems and microarray technologies. We provide our customers with an integrated product portfolio facilitating and improving multiplex analysis, high throughput screening and high throughput production of microarrays in the genomics and proteomics fields – from early research to manufacturing.

Silicon Valley Bank
For 25 years, Silicon Valley Bank has been dedicated to providing global financial services to some of the most innovative and entrepreneurial companies in the technology, life sciences, private equity and premium wine industries. Our experience with these industries affords us a deep understanding of our clients’ business models and a high level of comfort with the business cycles inherent to these dynamic markets.

Saul Ewing LLP
Saul Ewing LLP is a law firm that provides sophisticated legal services from offices in 11 locations along the East Coast. Attorneys specializing in different legal fields — corporate, litigation, real estate and insurance, in addition to patent law — are all a part of our life sciences team. We advise and represent life sciences industry clients in several areas, including patent preparation, prosecution and enforcement, medical device and Hatch-Waxman patent infringement and litigation.

SmithSolve provides a full range of corporate communications, public relations and patient advocacy services to biopharmaceutical companies. We are based in Morristown, NJ and work exclusively in healthcare. Capabilities include corporate branding, corporate strategy, corporate communications, digital design, employee engagement, executive and leadership communications, investor relations, issues management, media relations, product and pipeline communications, patient advocacy and social media.

S.R. One, Limited
S.R. One, Limited is the corporate venture capital arm of GlaxoSmithKline. Founded in 1985, S.R. One, Limited actively invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Our team of investment professionals experience spans basic science, industry and the market. We take an active role in our portfolio companies and work with management teams and our fellow venture investors to create significant value.

TayganPoint Consulting
TayganPoint Consulting Group is a management consulting firm based in Lambertville, NJ. The primary focus of TayganPoint is helping life sciences companies with business transformation and helping them improve their operations and effectively manage change. Our consultants average over 20 years of both industry and consulting experience with expertise in supply chain, sales and marketing, R&D, regulatory, finance, IT and shared services.

The Leadership Edge, Inc.
For over 25 years, The Leadership Edge has provided learning and development and consulting services to the life sciences and technology industries. We have developed industry specific programs, products and services based on our many years of industry knowledge using content that has a proven track record of success. Over 4,000 leaders, representing the industry’s top executives, managers and scientists have dramatically benefitted from their participation in a The Leadership Edge program, coaching or teambuilding experience. Partner with us and, you too, will be leveraging your company’s human capital, achieving scientific breakthroughs and creating an inspiring and productive work environment.

Ulteemit BioConsulting, LLC
Ulteemit Bioprocessing, LLC offers expert consultation in the fields of process development and manufacture of protein therapeutics. With over 30 years of experience in the biopharmaceutical industry, Dr. Michiel “Mike” E. Ultee provides both creative insight and a rich perspective into what it takes to turn a protein discovery into a therapeutic.

WithumSmith + Brown, PC
WithumSmith+Brown, PC (WS+B) ranks in the top 10 full service CPA firms in New Jersey. Serving some of the best companies across the Mid-Atlantic region and worldwide, WS+B offers a variety of services and specialized support to more than 12 major industry sectors, including the life sciences arena. Our team of 450 professionals, which includes 200 CPAs and 80 partners based in 12 offices in NJ, NY, PA, MD, CO and FL, brings a unique level of quality to every engagement, providing greater assurance, increased profitability and long-term growth. WithumSmith+Brown can help you “Be in a Position of Strength.”

ZenithBIO, LLC
Ruth Plager is the President of ZenithBIO LLC, a BioPharma Strategic Business Development & Strategic Marketing Consultancy designed to accelerate the business development goals of young, dynamic biopharmaceutical companies. In more than a decade of consulting, we have provided critical insights and analyses that strengthened the negotiating positions of our clients, primarily in the major biotech hubs. Our network and strategic analyses expand the bandwidth of our clients for the full range of partnering activities and commercialization for products at all stages of development.

BioNJ thanks our renewing Institutional Members:

Center for Healthcare Innovation, Stevens Institute of Technology
Founded in 1870, Stevens is a premier private coeducational institution focused on research and entrepreneurship. Stevens is committed to exploring the frontiers of engineering, science and management. Three schools and one college support the mission of the Institute. Creative and entrepreneurial research is an integral part of the Stevens mission. This is expressed through the concept of Technogenesis, a novel educational approach pioneered by the Institute. Technogenesis leverages the expertise of students, faculty and colleagues in industry to conceive, design and commercialize new technologies. Stevens’ 2008 ranking by Forbes Magazine as the nation’s third Top-Patent-Revenue-Generating University underscores the success of this endeavor.

FDU School of Pharmacy
Located in the heart of the U.S. pharmaceutical industry, FDU’s School of Pharmacy in Morris County, New Jersey, is unveiling a dynamic curriculum incorporating technology, a global perspective and multiple master’s degree options. The time is right for an innovative approach to pharmacy education because revolutionary developments are changing the field. The role of the pharmacist is expanding following health care reform legislation and the advent of personalized medicine. Only the second pharmacy school in the state of New Jersey, FDU’s School of Pharmacy offers a variety of classroom, lab and experiential opportunities to meet the learning styles of today’s students and prepare them for exciting and successful careers in the 21st century.

Hackensack University Medical Center
HackensackUMC, a nonprofit teaching and research hospital located in Bergen County, NJ, is the largest provider of inpatient and outpatient services in the state and is the flagship hospital of Hackensack University Health Network. HackensackUMC was listed as the number one hospital in New Jersey by the U.S. News & World Report’s Best Hospital 2014-15 rankings. In 2014, HackensackUMC received its fifth consecutive Magnet® designation for nursing excellence and it is one of the nation’s top 30 hospitals by receiving 11 national specialty rankings as well as 23 Gold Seals of Approval™ by the Joint Commission – more than any other hospital in the country.

Invest in Denmark
As part of the Ministry of Foreign Affairs of Denmark, Invest in Denmark is a customized one-stop service for foreign companies looking to set up a business in Denmark.  In North America, our team of 10 people are located at the official Danish representations in New York, Silicon Valley and Toronto. We focus in particular on developing partnerships within life sciences. You’ll find us in central hot spots around the world as part of the Ministry of Foreign Affairs of Denmark. Our specialized staff across the globe has the corporate background, industry insight and well-connected networks to advise you on every aspect of locating in Denmark.

Monmouth University
The School of Science houses four departments: Biology; Chemistry, Medical Technology and Physics; Mathematics and Computer Science and Software Engineering. The School is also the home for two Centers of Distinction, the Urban Coast Institute (UCI) and Rapid Response Institute (RRI). The School of Science offers undergraduate degree programs in biology, chemistry, clinical laboratory sciences, computer science, mathematics, medical technology and software engineering, and graduate degree programs in computer science and software engineering.

National Disease Research Interchange (NDRI)
The National Disease Research Interchange (NDRI) is a non-profit, NIH-funded organization that has been a leading provider of human organs and tissues for research for over 30 years. By serving as the liaison between tissue and organ donors and the scientific community, NDRI is uniquely positioned to support breakthrough research in health care on disease states like HIV AIDS, cancer, diabetes, arthritis, heart disease and many more.

Springer Nature
Nature Publishing Group (NPG) publishes journals, online databases and services across the life, physical, chemical and applied sciences. Focusing on the needs of scientists, Nature is the leading weekly, international scientific journal. NPG publishes a range of Nature research journals and Nature Reviews journals, prestigious academic and partner journals including society-owned publications. Online, provides access to NPG publications and services, including news and comment from Nature, and the leading scientific jobs boardNaturejobs. Scientific American is at the heart of NPG’s consumer media division and is the oldest continuously published magazine in the U.S .and the leading authoritative publication for science in the general media.

The College of New Jersey
The College of New Jersey is a highly-selective, mid-sized college that leads the northern region of the country as a top-tier public institution. Located in central New Jersey, the college’s nationally-ranked STEM and business programs create graduates who contribute as innovative leaders to the growth and prosperity of the region’s vibrant biotechnology cluster. TCNJ graduates are employed at many of the top biotech companies in and around New Jersey.

UK Trade & Investment
UK Trade & Investment (UKTI) is the commercial arm of the British government. We help UK companies expand abroad, and work with U.S. companies that are looking to set up or grow businesses in the UK/EU. Please get in touch if you’d like free information on R&D, clinical trials, commercial or funding opportunities in the UK.

We Work for Health
We Work for Health brings together leaders in research, medicine, public health, academia, education, labor and business to raise awareness of the importance of preserving medical innovation. This unique network seeks to demonstrate to federal policymakers, key opinion leaders and the media the need for strong public policy to promote innovation and, along with it, the health of Americans and the economy.